Viva BioInnovator
Shanghai, Shanghaivivabiotech.com
Overview
Viva BioInnovator is dedicated to investing globally in biotech innovation with novel solutions to unmet medical needs across multiple therapeutic areas ranging from biopharmaceuticals to devices, diagnostics, and life science tools. By leveraging Viva Biotech's rich experience and technical advantages in novel drug R&D, we provide both cash and in-kind services, also called Equity-for-Services (EFS), for our investments. We can also work with start-ups through our incubation track which offers value-added services in operations, logistical support, and more to support early-stage development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kainova Therapeutics | Feb 2026 | Series B | Co-investor |
| TechnoDerma Medicines Inc. | Jan 2024 | Early Funding | Co-investor |
| Reglagene | Dec 2023 | Series A | Co-investor |
| TechnoDerma Medicines Inc. | Jan 2023 | Series A Extension | Co-investor |
| Domain Therapeutics | May 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.